Cargando…
Tumor-induced osteomalacia
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome clinically characterized by bone pain, fractures and muscle weakness. It is caused by tumoral overproduction of fibroblast growth factor 23 (FGF23) that acts primarily at the proximal renal tubule, decreasing phosphate reabsorption a...
Autores principales: | Florenzano, Pablo, Gafni, Rachel I., Collins, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633085/ https://www.ncbi.nlm.nih.gov/pubmed/29021995 http://dx.doi.org/10.1016/j.bonr.2017.09.002 |
Ejemplares similares
-
Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia
por: Jan de Beur, Suzanne M., et al.
Publicado: (2022) -
SUN-364 Enthesophytes Are a Common Feature of FGF23-Mediated Hypophosphatemia Due to Tumor-Induced Osteomalacia
por: Gafni, Rachel Ilana, et al.
Publicado: (2020) -
Tumor-induced osteomalacia
por: Yin, Zinan, et al.
Publicado: (2018) -
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
por: Hartley, Iris R., et al.
Publicado: (2022) -
Epidemiology of Tumor-Induced Osteomalacia in Denmark
por: Abrahamsen, Bo, et al.
Publicado: (2021)